Elevated ATP1A1 levels have been associated with advanced cancer staging, reduced recurrence-free survival (RFS), and overall survival (OS) in gastric cancer [17] and hepatocellular carcinoma [18]. This evidence concerns the gene ATP1A1 and cancer.